Lundgren-Akerlund; Evy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lundgren-Akerlund; Evy.The latest application filed is for "integrin heterodimer and a subunit thereof".

Company Profile

0.5.18

Lundgren-Akerlund; Evy - Bjarred SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 10,087,253 - Lundgren-Akerlund October 2, 2	2018-10-02
Integrin heterodimer and a subunit thereof Grant 10,081,666 - Lundgren-Akerlund September 25, 2	2018-09-25
Integrin Heterodimer And A Subunit Thereof App 20180079795 - LUNDGREN-AKERLUND; Evy	2018-03-22
Integrin Heterodimer And A Subunit Thereof App 20170121386 - LUNDGREN-AKERLUND; Evy	2017-05-04
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1 App 20160319023 - Lundgren-Akerlund; Evy	2016-11-03
Integrin heterodimer and a subunit thereof Grant 8,895,253 - Lundgren-Akerlund November 25, 2	2014-11-25
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1 App 20140099716 - Lundgren-Akerlund; Evy	2014-04-10
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 8,563,255 - Lundgren-Akerlund October 22, 2	2013-10-22
Integrin Heterodimer And A Subunit Thereof App 20130137118 - LUNDGREN-AKERLUND; Evy	2013-05-30
Integrin Heterodimer And A Subunit Thereof App 20120136141 - Lundgren-Akerlund; Evy	2012-05-31
Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1 App 20120034625 - Lundgren-Akerlund; Evy	2012-02-09
Binding agents to the Integrin Alpha-11 subunit, and uses thereof App 20110256061 - Lundgren-Akerlund; Evy	2011-10-20
Marker For Stem Cells And Its Use App 20110033923 - Lundgren-Akerlund; Evy	2011-02-10
Use Of Integrin Alpha 10 Binding Antibody To Modulate Extracellular Matrix (cartilage) Turnover App 20100055114 - Lundgren-Akerlund; Evy	2010-03-04
Expansion and Differentiation of Mesenchymal Stem Cells App 20090232777 - Lundgren-Akerlund; Evy ; et al.	2009-09-17
Monoclonal antibody capable of binding integrin alpha 10 beta 1 App 20090185978 - Lundgren-Akerlund; Evy	2009-07-23
Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation App 20080159956 - Lundgren-Akerlund; Evy	2008-07-03
Antibody to an integrin heterodimer and/or a subunit thereof App 20060178503 - Lundgren-Akerlund; Evy	2006-08-10
Monoclonal antibody capable of binding integrin alpha 10 beta 1 App 20060127398 - Lundgren-Akerlund; Evy	2006-06-15
Knockout mice and their use App 20060123495 - Gullberg; Donald ; et al.	2006-06-08
Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation App 20050255182 - Lundgren-Akerlund, Evy	2005-11-17
Marker for stem cells and its use App 20050221327 - Lundgren-Akerlund, Evy	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.